The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients - Results of a double-blind, randomised pilot trial

被引：0
|
作者：
Haffmans, J
Oolders, JM
Hoencamp, E
Arends, JBAM
机构：
[1] Parnassia Psycho Med Centrum, The Hague, Netherlands
[2] Parnassia Res Ctr, The Hague, Netherlands
[3] Epilspsy Ctr Kempenhaeghe, Heeze, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [31] Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: Results of a randomized controlled double-blind trial
    Verhey, FRJ
    Verkaaik, M
    Lousbert, R
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 21 (01) : 1 - 8
  • [32] Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double-blind olanzapine trial
    Ishigooka, J
    Inada, T
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) : 403 - 414
  • [33] DOUBLE-BLIND PILOT TRIAL OF DESIPRAMINE VERSUS FLUOXETINE IN PANIC PATIENTS
    BYSTRITSKY, A
    ROSEN, RM
    MURPHY, KJ
    BOHN, P
    KEYS, SA
    VAPNIK, T
    ANXIETY, 1994, 1 (06): : 287 - 290
  • [34] ZOTEPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH PREVAILINGLY NEGATIVE SYMPTOMS - A DOUBLE-BLIND TRIAL VS HALOPERIDOL
    BARNAS, C
    STUPPACK, CH
    MILLER, C
    HARING, C
    SPERNERUNTERWEGER, B
    FLEISCHHACKER, WW
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 7 (01) : 23 - 27
  • [35] A double-blind randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers
    Arango, C
    Artaloytia, JF
    Lahti, A
    Sanz, J
    Pascual, A
    Cubero, P
    Prieto, D
    Palomo, T
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S113 - S114
  • [36] Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial
    Segal, J
    Berk, M
    Brook, S
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (03) : 176 - 180
  • [37] Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial
    Heck, AH
    Haffmans, PMJ
    de Groot, IW
    Hoencamp, E
    SCHIZOPHRENIA RESEARCH, 2000, 46 (2-3) : 97 - 105
  • [38] Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
    Dauvilliers, Yves
    Bassetti, Claudio
    Lammers, Gert Jan
    Amulf, Isabelle
    Mayer, Geert
    Rodenbeck, Andrea
    Lehert, Philippe
    Ding, Claire-Li
    Lecomte, Jeanne-Marie
    Schwartz, Jean-Charles
    LANCET NEUROLOGY, 2013, 12 (11): : 1068 - 1075
  • [39] A DOUBLE-BLIND COMPARISON OF BROMPERIDOL AND HALOPERIDOL IN NEWLY ADMITTED SCHIZOPHRENIC-PATIENTS
    BRANNEN, JO
    MCEVOY, JP
    WILSON, WH
    PETRIE, WM
    BAN, TA
    BERNEY, SA
    SCHAFFER, JD
    PHARMACOPSYCHIATRIA, 1981, 14 (04): : 139 - 140
  • [40] A DOUBLE-BLIND CONTROLLED TRIAL OF PIPOTIAZINE, HALOPERIDOL AND PLACEBO IN RECENTLY-HOSPITALIZED ACUTE SCHIZOPHRENIC-PATIENTS
    BECHELLI, LPC
    RUFFINONETTO, A
    HETEM, G
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1983, 16 (04) : 305 - 311
12345